Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,086,623
+$3,483,055 QoQ
Shares Held
49,991
+25.6% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
2.35%
of 13F equity value
Holder Rank
#108
of 870 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Mar 31, 2026CallValue
$18,797,466
CallShares
31,700
PutValue
$27,217,782
PutShares
45,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $121,812,965 across 10 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (22.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
213,407 | $35,967,615 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
49,991 | $27,086,623 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
401,208 | $16,461,564 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
146,403 | $16,241,948 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
480,715 | $8,321,176 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
444,173 | $7,120,093 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
172,489 | $4,244,954 | |
| 8 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
143,700 | $2,580,852 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,086,623 | 49,991 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $27,217,782 | 45,900 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $18,797,466 | 31,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $23,603,568 | 39,805 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $33,007,776 | 67,743 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $40,097,436 | 95,650 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,456,953 | 36,391 | Shares | Defined | 2025-08-14 | |
| 2024-12-31 | $18,524,100 | 52,500 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||